Metabolic Syndrome: An Important Risk Factor for Stroke, Alzheimer Disease, and Depression
Autor Akhlaq A. Farooquien Limba Engleză Paperback – 8 iul 2015
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (1) | 1198.44 lei 6-8 săpt. | |
| Springer – 8 iul 2015 | 1198.44 lei 6-8 săpt. | |
| Hardback (1) | 1210.37 lei 6-8 săpt. | |
| Springer – 14 iun 2013 | 1210.37 lei 6-8 săpt. |
Preț: 1198.44 lei
Preț vechi: 1461.51 lei
-18% Nou
Puncte Express: 1798
Preț estimativ în valută:
229.36€ • 238.24$ • 190.51£
229.36€ • 238.24$ • 190.51£
Carte tipărită la comandă
Livrare economică 04-18 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781489985798
ISBN-10: 1489985794
Pagini: 432
Ilustrații: XX, 412 p.
Dimensiuni: 155 x 235 x 23 mm
Greutate: 0.6 kg
Ediția:2013
Editura: Springer
Colecția Springer
Locul publicării:New York, NY, United States
ISBN-10: 1489985794
Pagini: 432
Ilustrații: XX, 412 p.
Dimensiuni: 155 x 235 x 23 mm
Greutate: 0.6 kg
Ediția:2013
Editura: Springer
Colecția Springer
Locul publicării:New York, NY, United States
V-ar putea interesa
-
Preț: 77.44 lei -
The Woman who Changed Her BrainBarbara Arrowsmith-Young-16%Preț: 69.45 lei82.72 lei -
The Oxford Handbook of Eye MovementsSimon Liversedge-20%Preț: 617.19 lei775.93 lei -
-30%Preț: 604.26 lei862.55 lei -
NeurogliaHelmut Kettenmann-30%Preț: 1856.60 lei2660.53 lei -
Brain Imaging: What it Can (and Cannot) Tell Us About ConsciousnessRobert G. Shulman-32%Preț: 496.37 lei726.01 lei -
Brain Aromatase, Estrogens, and BehaviorJacques Balthazart-34%Preț: 808.80 lei1223.02 lei -
Primate NeuroethologyMichael L. Platt-33%Preț: 779.18 lei1164.25 lei -
The Moral MoleculePaul J. ZakPreț: 100.08 lei -
Preț: 100.47 lei -
Neuromarketing in Action – How to Talk and Sell to the BrainPatrick M GeorgesPreț: 232.16 lei -
Mathematical Foundations of NeuroscienceG. Bard Ermentrout-15%Preț: 578.88 lei681.03 lei -
Transcranial Magnetic StimulationAlexander Rotenberg-18%Preț: 1376.57 lei1678.75 lei -
Phytochemicals & Human HealthAkhlaq A. Farooqui-27%Preț: 1937.43 lei2656.91 lei -
-27%Preț: 1110.33 lei1521.15 lei
Public țintă
ResearchCuprins
Chapter 1:The effect of unhealthy lifestyle on brain metabolism and function.- Chapter 2: The effect of metabolic syndrome on the brain.- Chapter 3: The Association of essential fatty acid metabolism in the pathogenesis of metabolic syndrome and neurological disorders.- Chapter 4: Contribution of lipid mediators to the pathogenesis of metabolic syndrome and neurological disorders.- Chapter 5: Molecular aspects of obesity and insulin resistance in metabolic syndrome and neurological disorders.- Chapter 6: Dietary interventions of metabolic syndrome and neurological disorders.- Chapter 7: Signal transduction processes and metabolic link among metabolic syndrome and stroke.- Chapter 8: Signal transduction processes and metabolic link among metabolic syndrome and Alzheimer’s disease.- Chapter 9: Signal transduction processes and metabolic link among metabolic syndrome and depression.- Chapter 10: Future research perspectives.
Textul de pe ultima copertă
The metabolic syndrome is a cluster of common pathologies: abdominal obesity linked to an excess of visceral fat, insulin resistance, dyslipidemia and hypertension. At the molecular level, metabolic syndrome is accompanied not only by dysregulation in the expression of adipokines, cytokines, and chemokines but also by alterations in insulin and leptin signaling, oxidative stress, and chronic low grade inflammation. These changes affect immune responses and mediate chronic inflammation leading to alterations in the hypothalamic ‘bodyweight/appetite/satiety set point’. It is becoming increasingly evident that metabolic syndrome is a risk factor for neurological disorders such as stroke, depression, and Alzheimer disease (AD). Family history, age, environmental and lifestyle factors (diet and physical inactivity, and exposure to toxins) are closely associated with predisposition for the development of metabolic syndrome as well as neurological disorders. The incidences of stroke are 2 to 4-fold higher in patients with metabolic syndrome and cardiovascular diseases compared to normal subjects of the same age. Similarly, patients with metabolic syndrome have a 2 to 3-fold increased risk for developing dementia and AD. Metabolic syndrome doubles the risk of depression. The molecular mechanism underlying the mirror relationship between metabolic syndrome and neurological disorders is not fully understood. However, biochemical alterations observed in metabolic syndrome like induction of chronic inflammation and oxidative stress, impairment of endothelial cell function, induction of insulin and leptin resistance, hyperglycemia-related increase in advanced glycation end-products, and micro-vascular injury may represent a pathological bridge between metabolic syndrome and neurological disorders.
It is hoped that Metabolic Syndrome: An important risk factor for stroke, Alzheimer disease, and depression will be useful to postgraduate students, faculty, research scientists, pharmacologists, nutritionists, and physicians, who are curious about the molecular mechanisms that link metabolic syndrome with stroke, Alzheimer disease, and depression.
It is hoped that Metabolic Syndrome: An important risk factor for stroke, Alzheimer disease, and depression will be useful to postgraduate students, faculty, research scientists, pharmacologists, nutritionists, and physicians, who are curious about the molecular mechanisms that link metabolic syndrome with stroke, Alzheimer disease, and depression.
Caracteristici
Provides a comprehensive description of signal transduction processes associated with the relationship between metabolic syndrome and neurological disorders Useful for understanding molecular aspects of metabolic syndrome and its relationship with neurological disorders Can be used as supplement text for a range of neuroscience and biochemistry courses Includes supplementary material: sn.pub/extras